Media Release
Ajman, May 13: THD SpA, an Italian equipment manufacturing company has entered into an agreement with the Gulf Medical College Hospital and Research Centre - Ajman, to be a Regional Surgical Training Centre for THD (Trans Anal Haemorrhoidal Dearterialization) surgical procedure.
The agreement was signed at the GMU campus by Thumbay Moideen, founder president GMC hospitals and Emad Labib of THD SpA, in the presence of Akbar Moideen Thumbay, director operations health care and retail divisions Thumbay Group and officials from THD.
“Hemorrhoids are not a frequently discussed topic. Most people simply tolerate the problem and are often frightened by the thought of a traditional surgery. The THD procedure offers a minimally invasive surgical approach to treating the source of the hemorrhoids. Post-operative pain is negligible; no bleeding and needs only a days' stay in the hospital; the patient can go for work within four to five days,”says professor Yasein Mallaha Taher, head, department of surgery, GMC hospital Ajman.
He said, “Clinical results have shown that patients who have THD may encounter less pain, less risk of complications and faster return to activities within 4 days.”
“GMC hospital will be a recognized center in the UAE and the Middle East for the THD company and their surgical procedures. Another new technology will be introduced in the near future for the management of anal fecal incontinence and the GMC hospital will be the first in the UAE and the Middle East to conduct the procedure. THD will nominate and sponsor surgeons from all over the region to be trained at our hospital,” added professor Taher.
Gulf Medical College Hospital and Research Centre Ajman will be the venue for any future professional activities sponsored by THD in UAE including foreign speakers/ trainers, symposia, round table discussions, workshops and so on.
THD is strong in its know-how for the past experiences in clinical, research and development, rapid prototyping and 3D design. THD SpA today is a known reality in science, thanks to the solid foundation on which it was built.
Currently THD SpA enjoys an international growing consensus and occupies a prominent position in the field of treatment of hemorrhoids. The high quality of the materials used backed with constant research in technology and medicine, the design and manufacture of innovative devices supported by a team of designers, researchers and physicians have allowed it to stand out within the framework of the colon proctology treatments.
The quality and effectiveness of products of THD, combined with prompt service have satisfied the demands of health care and medical centers in more than 50 countries. THD allows the company to become a landmark in the treatment of hemorrhoids.
Today the group has 60 THD people and makes use of a solid international distribution network supported by a pool of local specialists and researchers at the forefront in coloproctologia.